Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; often called FRAP-connected protein (FRP1)) has emerged for a promising method for cancer treatment that exploits synthetic lethal interactions with proteins associated with DNA problems maintenance, overcomes resistance to other therapies and improves antitumour immunity. Se... https://g15066532.bloggactivo.com/26495979/mobocertinib-an-overview